Optimizing Anesthesia for Post Partum Tubal Ligations
Optimizing Anesthesia for Post Partum Tubal Ligations
In this study, the investigators will compare CLOROTEKAL® (1% spinal chloroprocaine) to
 low-dose isobaric bupivacaine using the epidural volume extension (EVE) technique in patients
 undergoing post-partum tubal ligation (PPBTL). This will be a randomized, double-blinded
 study. Patients scheduled for PPBTL at the Women and Infants Center (WIC) will be eligible
 for enrollment in this study. Outcomes measured will include: ability to achieve an adequate
 level required for surgery (T6), rate of epidural activation, and duration of the block. The
 investigators hope to determine the usefulness of each drug using the EVE technique in the
 setting of PPBTL.
Inclusion Criteria:

 -  Any patient scheduled for a postpartum tubal ligation at the Women and Infants Center
 will be eligible for the study

 Exclusion Criteria:

 -  age less than 18 years old

 -  allergy to either local anesthetic class (amide or ester)

 -  contraindication to spinal anesthesia